Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ginell Post

Concepts (238)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
3
2019
51
1.110
Why?
Lymphoma, Large B-Cell, Diffuse
4
2024
106
0.870
Why?
Plasma Cells
4
2018
238
0.870
Why?
Epidural Neoplasms
1
2019
5
0.730
Why?
ABO Blood-Group System
1
2019
14
0.730
Why?
Spinal Cord Compression
1
2019
10
0.720
Why?
von Willebrand Factor
1
2019
53
0.710
Why?
Pseudolymphoma
1
2018
4
0.680
Why?
Monocytes
1
2019
156
0.680
Why?
Scalp Dermatoses
1
2018
8
0.670
Why?
Pulmonary Embolism
1
2019
106
0.650
Why?
Antigens, CD
1
2019
242
0.650
Why?
Tumor Microenvironment
1
2019
209
0.650
Why?
Hematologic Neoplasms
1
2019
99
0.640
Why?
Blood Coagulation Tests
1
2017
23
0.630
Why?
Optics and Photonics
1
2017
13
0.630
Why?
Endemic Diseases
1
2017
29
0.620
Why?
Diagnostic Tests, Routine
1
2017
31
0.610
Why?
Immunoglobulins
1
2017
89
0.600
Why?
Histoplasmosis
1
2017
53
0.600
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.520
Why?
Receptors, Antigen, B-Cell
1
2015
9
0.520
Why?
Interleukin-6
1
2016
315
0.510
Why?
Leukemoid Reaction
1
2014
7
0.510
Why?
Liposarcoma
1
2014
24
0.500
Why?
Antifungal Agents
1
2017
363
0.500
Why?
Muscle Neoplasms
1
2014
21
0.500
Why?
Neoplasms, Second Primary
1
2014
77
0.480
Why?
Lymphoma
3
2024
72
0.470
Why?
Sarcoma
1
2014
73
0.460
Why?
Neutrophils
1
2014
154
0.460
Why?
Afibrinogenemia
1
2012
5
0.440
Why?
Fetomaternal Transfusion
1
2012
3
0.440
Why?
Plasma Exchange
1
2012
33
0.420
Why?
Carcinoma, Neuroendocrine
1
2012
27
0.420
Why?
Cell Differentiation
1
2015
720
0.410
Why?
Liver
1
2017
1225
0.390
Why?
Humans
28
2024
54284
0.390
Why?
Graft vs Host Disease
1
2011
83
0.370
Why?
Myeloproliferative Disorders
1
2010
28
0.370
Why?
In Situ Hybridization, Fluorescence
1
2011
278
0.360
Why?
Bone Neoplasms
1
2011
193
0.340
Why?
Liver Transplantation
1
2011
160
0.330
Why?
Translocation, Genetic
1
2010
287
0.330
Why?
Multiple Myeloma
4
2019
3035
0.320
Why?
Phenotype
2
2019
820
0.280
Why?
Pancytopenia
3
2011
40
0.270
Why?
Receptors, Adrenergic, alpha-1
2
2003
12
0.270
Why?
Immunohistochemistry
3
2017
1089
0.260
Why?
Male
12
2022
27334
0.250
Why?
Female
11
2022
28441
0.230
Why?
Lymph Nodes
2
2016
284
0.230
Why?
Peptide Hydrolases
2
2014
67
0.220
Why?
Macrophages
2
2019
405
0.220
Why?
Diagnosis, Differential
3
2018
1136
0.220
Why?
Rad52 DNA Repair and Recombination Protein
1
2022
3
0.210
Why?
Immunoglobulin Class Switching
1
2022
8
0.210
Why?
Immunoglobulin D
1
2022
4
0.210
Why?
Enzyme Activators
1
2002
8
0.210
Why?
Mitogen-Activated Protein Kinases
2
2003
169
0.210
Why?
Adrenergic alpha-Agonists
1
2002
18
0.210
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
164
0.210
Why?
JNK Mitogen-Activated Protein Kinases
1
2002
78
0.210
Why?
Biopsy
2
2016
692
0.200
Why?
Middle Aged
5
2019
13088
0.200
Why?
Tissue Array Analysis
1
2019
50
0.180
Why?
Paraffin Embedding
1
2019
56
0.180
Why?
Sarcoma, Myeloid
1
2019
22
0.180
Why?
Glycosylation
1
2019
112
0.180
Why?
Bacterial Proteins
2
2014
454
0.170
Why?
Lung Neoplasms
2
2024
642
0.170
Why?
Adolescent
3
2019
6897
0.170
Why?
Aged, 80 and over
2
2018
3431
0.170
Why?
Color
1
2018
29
0.160
Why?
Automation
1
2018
18
0.160
Why?
Lymphatic Vessels
1
2018
47
0.160
Why?
Partial Thromboplastin Time
1
2017
12
0.160
Why?
Myocytes, Cardiac
2
2013
137
0.160
Why?
Prothrombin Time
1
2017
19
0.160
Why?
Immunophenotyping
1
2018
117
0.160
Why?
Failure to Thrive
1
2017
21
0.160
Why?
Histoplasma
1
2017
29
0.160
Why?
Clonal Evolution
1
2018
60
0.150
Why?
Rare Diseases
1
2017
46
0.150
Why?
Endothelial Cells
1
2019
294
0.150
Why?
Blood Coagulation
1
2017
69
0.150
Why?
Vomiting
1
2017
73
0.150
Why?
Biopsy, Needle
1
2017
195
0.150
Why?
Young Adult
2
2019
4318
0.140
Why?
High-Throughput Nucleotide Sequencing
1
2018
206
0.140
Why?
Neoplasm, Residual
1
2017
166
0.140
Why?
Lung
1
2019
507
0.140
Why?
Bone Marrow
1
2018
411
0.140
Why?
Risk Assessment
2
2017
1361
0.130
Why?
Algorithms
1
2019
697
0.130
Why?
Weight Loss
1
2017
271
0.130
Why?
V(D)J Recombination
1
2015
4
0.130
Why?
Flow Cytometry
1
2018
546
0.130
Why?
Pyridines
2
2008
137
0.120
Why?
Fatal Outcome
1
2014
225
0.120
Why?
Neoplasm Metastasis
2
2012
252
0.120
Why?
Protein Kinases
1
2014
89
0.120
Why?
Aged
3
2019
10054
0.120
Why?
Methicillin-Resistant Staphylococcus aureus
1
2014
88
0.110
Why?
Polymerase Chain Reaction
1
2015
531
0.110
Why?
Transcription Factors
2
2014
622
0.110
Why?
Rh Isoimmunization
1
2012
2
0.110
Why?
Rho(D) Immune Globulin
1
2012
3
0.110
Why?
Mice
7
2024
6413
0.110
Why?
Chromogranins
1
2012
5
0.110
Why?
Pregnancy Complications, Hematologic
1
2012
14
0.110
Why?
Synaptophysin
1
2012
9
0.110
Why?
Vimentin
1
2012
33
0.110
Why?
Immunoenzyme Techniques
1
2012
165
0.100
Why?
Follow-Up Studies
1
2017
2387
0.100
Why?
Virulence Factors
1
2012
92
0.100
Why?
Leukemia, Myelomonocytic, Chronic
1
2011
17
0.100
Why?
Animals
9
2024
14385
0.100
Why?
Leukocytosis
1
2011
14
0.100
Why?
Antineoplastic Agents
2
2012
1300
0.100
Why?
Chimerism
1
2011
8
0.100
Why?
Plateletpheresis
1
2010
8
0.100
Why?
Telomerase
1
2010
30
0.100
Why?
Blood Preservation
1
2010
29
0.100
Why?
Myelodysplastic Syndromes
1
2011
79
0.100
Why?
Chromosomes, Human, Pair 8
1
2010
17
0.100
Why?
Infant
2
2017
3817
0.090
Why?
Chromosomes, Human, Pair 3
1
2010
20
0.090
Why?
Chromosomes, Human, Pair 9
1
2010
20
0.090
Why?
Gene Expression Regulation, Bacterial
1
2012
244
0.090
Why?
Adult
3
2019
14207
0.090
Why?
Keratinocytes
1
2011
96
0.090
Why?
Blood Proteins
1
2010
100
0.090
Why?
Retrospective Studies
2
2019
6432
0.090
Why?
Anaphylaxis
1
2010
71
0.090
Why?
CD8-Positive T-Lymphocytes
1
2011
116
0.090
Why?
Bone Marrow Cells
1
2011
233
0.090
Why?
Neural Tube Defects
1
2008
29
0.080
Why?
Staphylococcus aureus
1
2012
361
0.080
Why?
Thoracic Wall
1
2008
9
0.080
Why?
Copper
1
2008
48
0.080
Why?
Benzenesulfonates
1
2008
12
0.080
Why?
Nerve Sheath Neoplasms
1
2008
23
0.080
Why?
Treatment Outcome
2
2017
5604
0.080
Why?
Neurilemmoma
1
2008
28
0.080
Why?
Blood Platelets
1
2010
269
0.080
Why?
Cells, Cultured
3
2013
1737
0.080
Why?
Atherosclerosis
1
2010
249
0.080
Why?
Skin
1
2011
469
0.070
Why?
Mice, Knockout
3
2022
926
0.070
Why?
Inflammation
1
2010
674
0.070
Why?
Isoenzymes
2
2003
177
0.060
Why?
Pregnancy
1
2012
2620
0.060
Why?
Infant, Newborn
1
2012
2907
0.060
Why?
Uridine Triphosphate
1
2003
13
0.060
Why?
Heart
2
2003
360
0.060
Why?
Catheter-Related Infections
2
2014
55
0.060
Why?
Chromosome Aberrations
2
2018
316
0.060
Why?
Virulence
2
2014
194
0.050
Why?
Disease Models, Animal
3
2014
1639
0.050
Why?
Adrenergic alpha-1 Receptor Agonists
1
2002
3
0.050
Why?
Thymidine
1
2002
18
0.050
Why?
Bacteremia
2
2014
101
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2002
39
0.050
Why?
MAP Kinase Kinase 4
1
2002
34
0.050
Why?
Primary Cell Culture
1
2022
65
0.050
Why?
Gene Knockdown Techniques
1
2022
125
0.050
Why?
Adenosine Triphosphate
1
2003
242
0.050
Why?
p38 Mitogen-Activated Protein Kinases
1
2002
99
0.050
Why?
Recombination, Genetic
1
2022
108
0.050
Why?
Enzyme Activation
1
2002
329
0.050
Why?
B-Lymphocytes
1
2022
176
0.050
Why?
Cell Division
1
2002
330
0.050
Why?
Imidazoles
1
2002
142
0.050
Why?
Methionine
1
2002
146
0.050
Why?
Blotting, Western
1
2002
683
0.050
Why?
Phosphorylation
1
2022
614
0.050
Why?
Myocardium
1
2003
441
0.050
Why?
Carrier Proteins
1
2002
359
0.040
Why?
Fibroblasts
1
2002
386
0.040
Why?
Cell Line, Tumor
1
2024
1550
0.040
Why?
DNA-Binding Proteins
1
2022
462
0.040
Why?
Rats
2
2003
3415
0.040
Why?
Pathology, Molecular
1
2018
24
0.040
Why?
DNA
1
2002
581
0.040
Why?
Mice, Transgenic
2
2013
656
0.040
Why?
Cell Transformation, Neoplastic
1
2018
200
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2013
17
0.030
Why?
Animals, Outbred Strains
1
2012
13
0.030
Why?
Daptomycin
1
2012
33
0.030
Why?
Microbial Sensitivity Tests
1
2012
290
0.030
Why?
Prognosis
1
2017
2118
0.030
Why?
Cell Survival
1
2013
657
0.020
Why?
Karyotyping
1
2011
92
0.020
Why?
Isotonic Solutions
1
2010
21
0.020
Why?
P-Selectin
1
2010
33
0.020
Why?
Platelet Transfusion
1
2010
32
0.020
Why?
Biofilms
1
2012
200
0.020
Why?
Receptors, LDL
1
2010
70
0.020
Why?
Lymphoma, Large-Cell, Anaplastic
1
2010
13
0.020
Why?
Platelet Aggregation
1
2010
82
0.020
Why?
Platelet Activation
1
2010
50
0.020
Why?
Sodium Chloride
1
2010
67
0.020
Why?
Time Factors
1
2017
3213
0.020
Why?
Lipopolysaccharides
1
2010
199
0.020
Why?
Hypersensitivity
1
2010
82
0.020
Why?
Staphylococcal Infections
1
2012
300
0.020
Why?
Short Bowel Syndrome
1
2008
15
0.020
Why?
Parenteral Nutrition, Total
1
2008
26
0.020
Why?
Lipoproteins, LDL
1
2010
195
0.020
Why?
NF-kappa B
1
2010
335
0.020
Why?
Coronary Vessels
1
2010
197
0.020
Why?
Phenylurea Compounds
1
2008
16
0.020
Why?
Tumor Necrosis Factor-alpha
1
2010
434
0.020
Why?
Niacinamide
1
2008
25
0.020
Why?
Enterocolitis, Necrotizing
1
2008
36
0.020
Why?
Radiography, Thoracic
1
2008
69
0.020
Why?
Protein Kinase Inhibitors
1
2008
216
0.020
Why?
Anti-Bacterial Agents
1
2012
820
0.020
Why?
Brain Neoplasms
1
2008
284
0.020
Why?
Mutation
1
2011
1501
0.020
Why?
Purinergic P1 Receptor Antagonists
1
2003
2
0.010
Why?
Purinergic P2 Receptor Antagonists
1
2003
4
0.010
Why?
Phospholipase C gamma
1
2003
4
0.010
Why?
Adrenergic Agonists
1
2003
7
0.010
Why?
Phospholipase C beta
1
2003
2
0.010
Why?
Type C Phospholipases
1
2003
15
0.010
Why?
Phenylephrine
1
2003
34
0.010
Why?
Perfusion
1
2003
40
0.010
Why?
Hypertrophy
1
2003
52
0.010
Why?
Vasoconstriction
1
2003
60
0.010
Why?
Cyclic AMP
1
2003
106
0.010
Why?
Aorta
1
2003
177
0.010
Why?
Animals, Newborn
1
2003
396
0.010
Why?
Electrocardiography
1
2003
290
0.010
Why?
Magnetic Resonance Imaging
1
2008
1604
0.010
Why?
Dose-Response Relationship, Drug
1
2003
1476
0.010
Why?
Rats, Sprague-Dawley
1
2003
1663
0.010
Why?
Post's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description